Hyperhomocysteinemia in Alzheimer's disease: The hen and the egg?

Journal of Alzheimer's Disease

Volumn 33, Issue 4, 2013, Pages 1097-1104

  Farkas, Melinda ^a   Keskitalo, Salla ^a   Smith, Desiree E C ^b   Bain, Nadja ^a   Semmler, Alexander ^a   Ineichen, Benjamin ^a   Smulders, Yvo ^b   Blom, Henk ^b   Kulic, Luka ^a,c   Linnebank, Michael ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; diet; folic acid; homocysteine; hyperhomocysteinemia; mice; transgenic; vitamin B12; vitamin B6

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; AMYLOID BETA PROTEIN; FOLIC ACID; HOMOCYSTEINE;

ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; FEMALE; HYPERHOMOCYSTEINEMIA; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; RISK FACTOR; TRANSGENIC MOUSE;

EID: 84873677226     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121378     Document Type: Article

References (41)

1. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346, 476-483
2. Mudd SH, Levy HL, Skovby F (1995) Disorders of transsulfuration, McGraw-Hill, New York
3. Zhuo JM, Wang H, Pratico D (2011) Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32, 562-571
4. Fuso A, Nicolia V, Cavallaro RA, Ricceri L, D'Anselmi F, Coluccia P, Calamandrei G, Scarpa S (2008) Bvitamin deprivation induces hyperhomocysteinemia and brain S-Adenosylhomocysteine, depletes brain Sadenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 37, 731-746
5. Linnebank M, Linnebank A, Jeub M, Klockgether T, Wullner U, Kolsch H, Heun R, Koch HG, Suormala T, Fowler B (2004) Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am J Med Genet A 131, 101-102
6. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM(1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 1449-1455
7. Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F (2010) Sadenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis 7, 373-378
8. Kim JM, Kim SW, Shin IS, Yang SJ, Park WY, Kim SJ, Shin HY, Yoon JS (2008) Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 5, 36-40
9. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM (2006) A controlled trial of homocysteine lowering and cognitive performance.NEngl J Med 354, 2764-2772
10. Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S,VellasB(2010) B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia:Asystematic review. J Alzheimers Dis 22, 205-224
11. Malouf M, Grimley EJ (2008) Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 4, CD004514
12. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One 5, e12244
13. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517
14. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80, 114-122
15. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82, 636-643
16. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, Seeman TE (2005) Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 118, 161-167
17. Hagnelius NO, Wahlund LO, Nilsson TK (2008) CSF/serum folate gradient: Physiology and determinants with special reference to dementia. Dement Geriatr Cogn Disord 25, 516-523
18. Serot JM, Christmann D, Dubost T, Bene MC, Faure GC (2001) CSF-folate levels are decreased in late-onset AD patients. J Neural Transm 108, 93-99
19. Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K (2011) Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: A case control study. Eur Neurol 65, 270-278
20. Mulder C, Schoonenboom NS, Jansen EE, Verhoeven NM, van Kamp GJ, Jakobs C, Scheltens P (2005) The transmethylation cycle in the brain of Alzheimer patients. Neurosci Lett 386, 69-71
21. Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kolsch H, Frommann I, Kornhuber J, Maier W, Jessen F (2009) Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis 18, 819-828
22. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH (1990) Cerebrospinal fluid Sadenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-Adenosylmethionine. J Neurol Neurosurg Psychiatry 53, 1096-1098
23. Morrison LD, Smith DD, Kish SJ (1996) Brain Sadenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67, 1328-1331
24. Knobloch M, Konietzko U, Krebs DC, Nitsch RM (2007) Intracellular Abeta and cognitive deficits precede betaamyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 28, 1297-1306
25. Ubbink JB, Hayward Vermaak WJ, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565, 441-446
26. Smith DE, Kok RM, Teerlink T, Jakobs C, Smulders YM (2006) Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-Tandem mass spectrometry. Clin Chem Lab Med 44, 450-459
27. Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B (2001) Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? J Neurol Neurosurg Psychiatry 70, 419
28. Fuchs D, Jaeger M,Widner B,Wirleitner B, Artner-Dworzak E, Leblhuber F (2001) Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med 39, 691-694
29. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain.Areview. Free Radic Res 36, 1307-1313
30. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664
31. Hoffman M (2011) Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses 77, 1088-1093
32. Perna AF, Ingrosso D, De Santo NG (2003) Homocysteine and oxidative stress. Amino Acids 25, 409-417
33. Bernardo A, McCord M, Troen AM, Allison JD, McDonald MP (2007) Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol Aging 28, 1195-1205
34. Santiard-Baron D, Aupetit J, JanelN(2005) Plasma homocysteine levels are not increased in murine models of Alzheimer's disease. Neurosci Res 53, 447-449
35. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22, 1752-1762
36. Scarpa S, Fuso A, D'Anselmi F, Cavallaro RA (2003) Presenilin 1 gene silencing by S-Adenosylmethionine: A treatment for Alzheimer disease? FEBS Lett 541, 145-148
37. Fuso A, Cavallaro RA, NicoliaV, Scarpa S (2012) PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. Curr Alzheimer Res 9, 527-535
38. Chan A, Shea TB (2007) Folate deprivation increases presenilin expression, gamma-secretase activity, and Abeta levels in murine brain: Potentiation by ApoE deficiency and alleviation by dietary S-Adenosyl methionine. J Neurochem 102, 753-760
39. Zhuo JM, Pratico D (2010) Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol 45, 195-201
40. Fuso A, NicoliaV, Ricceri L, Cavallaro RA, Isopi E, Mangia F, FiorenzaMT, Scarpa S (2012) S-Adenosylmethionine reduces the progress of the Alzheimer-like features induced by Bvitamin deficiency in mice. Neurobiol Aging 33, 1482.e1-e16
41. Zhuo JM, Pratico D (2010) Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease. FASEB J 24, 3895-3902